The DOI matches its Crossref record; 232 of the 232 references it cites were found in a registry or an index.
Treatment of invasive fungal infections in cancer patients—updated recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)
Open accessAbstract
The Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO) here presents its updated recommendations for the treatment of documented fungal infections. Invasive fungal infections are a main cause of morbidity and mortality in cancer patients undergoing intensive chemotherapy regimens. In recent years, new antifungal agents have been licensed, and agents already approved have been studied in new indications. The choice of the most appropriate antifungal treatment depends on the fungal species suspected or identified, the patient's risk factors (e.g., length and depth of neutropenia), and the expected side effects. This guideline reviews the clinical studies that served as a basis for the following recommendations. All recommendations including the levels of evidence are summarized in tables to give the reader rapid access to the information.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis
Herbrecht, R., Denning, D. W., Patterson, T. F., Bennett, J. E., Greene, R. E., Oestmann, J.-W., Kern, W. V., Marr, K. A., Ribaud, P., Lortholary, O., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020191 · Cited by 3,304
Infectious Diseases Society of America
Enders, J. F. (1969) · Journal of Infectious Diseases · doi:10.1093/infdis/119.3.317 · Cited by 3,286
Pappas, P. G., Kauffman, C. A., Andes, D., Benjamin, D. K., Calandra, T. F., Edwards, J. E., Filler, S. G., Fisher, J. F., Kullberg, B.-J., Zeichner, L. O., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/596757 · Cited by 3,191 · cited 4×
“Treatment should be continued for an additional 4 weeks following the resolution of manifestations (BIII) [124, 127].”
BackgroundInfluentialEpidemiology and Outcome of Zygomycosis: A Review of 929 Reported Cases
Roden, M. M., Zaoutis, T. E., Buchanan, W. L., Knudsen, T. A., Sarkisova, T. A., Schaufele, R. L., Sein, M., Sein, T., Chiou, C. C., Chu, J. H., et al. (2005) · Clinical Infectious Diseases · doi:10.1086/432579 · Cited by 3,044
Walsh, T. J., Anaissie, E. J., Denning, D. W., Herbrecht, R., Kontoyiannis, D. P., Marr, K. A., Morrison, V. A., Segal, B. H., Steinbach, W. J., Stevens, D. A., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/525258 · Cited by 2,706
Perfect, J. R., Dismukes, W. E., Dromer, F., Goldman, D. L., Graybill, J. R., Hamill, R. J., Harrison, T. S., Larsen, R. A., Lortholary, O., Nguyen, M.-H., et al. (2010) · Clinical Infectious Diseases · doi:10.1086/649858 · Cited by 2,660
Ascioglu, S., Rex, J. H., de Pauw, B., Bennett, J. E., Bille, J., Crokaert, F., Denning, D. W., Donnelly, J. P., Edwards, J. E., Erjavec, Z., et al. (2002) · Clinical Infectious Diseases · doi:10.1086/323335 · Cited by 2,331
Smith, T. J., Khatcheressian, J., Lyman, G. H., Ozer, H., Armitage, J. O., Balducci, L., Bennett, C. L., Cantor, S. B., Crawford, J., Cross, S. J., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.4451 · Cited by 1,636
Guidelines for Treatment of Candidiasis
Pappas, P. G., Rex, J. H., Sobel, J. D., Filler, S. G., Dismukes, W. E., Walsh, T. J., & Edwards, J. E. (2004) · Clinical Infectious Diseases · doi:10.1086/380796 · Cited by 1,440
Aspergillosis Case-Fatality Rate: Systematic Review of the Literature
Lin, S.-J., Schranz, J., & Teutsch, S. M. (2001) · Clinical Infectious Diseases · doi:10.1086/318483 · Cited by 1,409
Comparison of Caspofungin and Amphotericin B for Invasive Candidiasis
Mora-Duarte, J., Betts, R., Rotstein, C., Colombo, A. L., Thompson-Moya, L., Smietana, J., Lupinacci, R., Sable, C., Kartsonis, N., & Perfect, J. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021585 · Cited by 1,380
Morrell, M., Fraser, V. J., & Kollef, M. H. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.9.3640-3645.2005 · Cited by 1,286
Liposomal Amphotericin B for Empirical Therapy in Patients with Persistent Fever and Neutropenia
Walsh, T. J., Finberg, R. W., Arndt, C., Hiemenz, J., Schwartz, C., Bodensteiner, D., Pappas, P., Seibel, N., Greenberg, R. N., Dummer, S., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903113401004 · Cited by 1,205
Garey, K. W., Rege, M., Pai, M. P., Mingo, D. E., Suda, K. J., Turpin, R. S., & Bearden, D. T. (2006) · Clinical Infectious Diseases · doi:10.1086/504810 · Cited by 1,171 · cited 1×
“The high pathogen-related mortality, which may approach 50 %, should prompt immediate initiation of therapy in all patients with suspected yeasts in the blood culture, as delays in treatment result in an increased mortality [48, 111].”
BackgroundPractice Guidelines for the Management of Cryptococcal Disease
Saag, M. S., Graybill, R. J., Larsen, R. A., Pappas, P. G., Perfect, J. R., Powderly, W. G., Sobel, J. D., Dismukes, W. E., & Mycoses Study Group Cryptococcal Subproject (2000) · Clinical Infectious Diseases · doi:10.1086/313757 · Cited by 1,105
Aapro, M. S., Bohlius, J., Cameron, D. A., Lago, L. D., Donnelly, J. P., Kearney, N., Lyman, G. H., Pettengell, R., Tjan-Heijnen, V. C., Walewski, J., et al. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2010.10.013 · Cited by 1,090
Rex, J. H., Bennett, J. E., Sugar, A. M., Pappas, P. G., van der Horst, C. M., Edwards, J. E., Washburn, R. G., Scheld, W. M., Karchmer, A. W., Dine, A. P., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411173312001 · Cited by 1,039
(2006) · PubMed · Cited by 906
Anidulafungin versus Fluconazole for Invasive Candidiasis
Reboli, A. C., Rotstein, C., Pappas, P. G., Chapman, S. W., Kett, D. H., Kumar, D., Betts, R., Wible, M., Goldstein, B. P., Schranz, J., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066906 · Cited by 894 · cited 2×
“In general, echinocandins (anidulafungin, caspofungin, and micafungin) have been tested for the treatment of candidemia in various controlled clinical trials [86, 110, 143], but the number of neutropenic patients in these trials was limited (max.”
BackgroundPascual, A., Calandra, T., Bolay, S., Buclin, T., Bille, J., & Marchetti, O. (2008) · Clinical Infectious Diseases · doi:10.1086/524669 · Cited by 887
Bennett, J. E., Dismukes, W. E., Duma, R. J., Medoff, G., Sande, M. A., Gallis, H., Leonard, J., Fields, B. T., Bradshaw, M., Haywood, H., et al. (1979) · New England Journal of Medicine · doi:10.1056/nejm197907193010303 · Cited by 863
Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis
Denning, D. W., Ribaud, P., Milpied, N., Caillot, D., Herbrecht, R., Thiel, E., Haas, A., Ruhnke, M., & Lode, H. (2002) · Clinical Infectious Diseases · doi:10.1086/324620 · Cited by 844 · cited 2×
“Voriconazole In an open, non-comparative study, voriconazole showed a response rate of 59 % in the primary treatment of invasive aspergillosis and a 38 % response rate when used for salvage treatment [41].”
BackgroundSelf-citationTreatment of Cryptococcal Meningitis Associated with the Acquired Immunodeficiency Syndrome
van der Horst, C. M., Saag, M. S., Cloud, G. A., Hamill, R. J., Graybill, J. R., Sobel, J. D., Johnson, P. C., Tuazon, C. U., Kerkering, T., Moskovitz, B. L., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199707033370103 · Cited by 820
Neofytos, D., Horn, D., Anaissie, E., Steinbach, W., Olyaei, A., Fishman, J., Pfaller, M., Chang, C., Webster, K., & Marr, K. (2009) · Clinical Infectious Diseases · doi:10.1086/595846 · Cited by 801
Practice Guidelines for Diseases Caused by Aspergillus
Stevens, D. A., Kan, V. L., Judson, M. A., Morrison, V. A., Dummer, S., Denning, D. W., Bennett, J. E., Walsh, T. J., Patterson, T. F., & Pankey, G. A. (2000) · Clinical Infectious Diseases · doi:10.1086/313756 · Cited by 789
Infections Caused by Scedosporium spp
Cortez, K. J., Roilides, E., Quiroz-Telles, F., Meletiadis, J., Antachopoulos, C., Knudsen, T., Buchanan, W., Milanovich, J., Sutton, D. A., Fothergill, A., et al. (2008) · Clinical Microbiology Reviews · doi:10.1128/cmr.00039-07 · Cited by 786
Kuhn, D. M., George, T., Chandra, J., Mukherjee, P. K., & Ghannoum, M. A. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.6.1773-1780.2002 · Cited by 764
Walsh, T. J., Raad, I., Patterson, T. F., Chandrasekar, P., Donowitz, G. R., Graybill, R., Greene, R. E., Hachem, R., Hadley, S., Herbrecht, R., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/508774 · Cited by 752
Cornely, O. A., Maertens, J., Bresnik, M., Ebrahimi, R., Ullmann, A. J., Bouza, E., Heussel, C. P., Lortholary, O., Rieger, C., Boehme, A., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/514341 · Cited by 751
Self-citationSkiada, A., Pagano, L., Groll, A., Zimmerli, S., Dupont, B., Lagrou, K., Lass-Florl, C., Bouza, E., Klimko, N., Gaustad, P., et al. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2010.03456.x · Cited by 748
Caillot, D., Casasnovas, O., Bernard, A., Couaillier, J. F., Durand, C., Cuisenier, B., Solary, E., Piard, F., Petrella, T., Bonnin, A., et al. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.1.139 · Cited by 706
Kuse, E.-R., Chetchotisakd, P., da Cunha, C. A., Ruhnke, M., Barrios, C., Raghunadharao, D., Sekhon, J. S., Freire, A., Ramasubramanian, V., Demeyer, I., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60605-9 · Cited by 692
Self-citationVoriconazole Treatment for Less‐Common, Emerging, or Refractory Fungal Infections
Perfect, J. R., Marr, K. A., Walsh, T. J., Greenberg, R. N., DuPont, B., de la Torre‐Cisneros, J., Just‐Nubling, G., Schlamm, H. T., Lutsar, I., Espinel‐Ingroff, A., et al. (2003) · Clinical Infectious Diseases · doi:10.1086/374557 · Cited by 680
Blumberg, H. M., Jarvis, W. R., Soucie, J. M., Edwards, J. E., Patterson, J. E., Pfaller, M. A., Rangel‐Frausto, M. S., Rinaldi, M. G., Saiman, L., Wiblin, R. T., et al. (2001) · Clinical Infectious Diseases · doi:10.1086/321811 · Cited by 661
Segal, B. H. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0808853 · Cited by 661
León, C., Ruiz-Santana, S., Saavedra, P., Almirante, B., Nolla-Salas, J., Álvarez-Lerma, F., Garnacho-Montero, J., & León, M. Á. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000202208.37364.7d · Cited by 659 · cited 1×
“Colonization index and Candida scores have been developed to predict invasive Candida infections for non-neutropenic patients in the ICU [94], but are not validated for patients with hematological malignancies.”
BackgroundMaertens, J., Raad, I., Petrikkos, G., Boogaerts, M., Selleslag, D., Petersen, F. B., Sable, C. A., Kartsonis, N. A., Ngai, A., Taylor, A., et al. (2004) · Clinical Infectious Diseases · doi:10.1086/423381 · Cited by 658
Parczewska, O. K., Posaconazol, przeciwgrzybicze, L., Anidulafungina, Micafungina, & wrażliwość, O. (2009) · Cited by 656
Micafungin versus Caspofungin for Treatment of Candidemia and Other Forms of Invasive Candidiasis
Pappas, P. G., Rotstein, C. M. F., Betts, R. F., Nucci, M., Talwar, D., De Waele, J. J., Vazquez, J. A., Dupont, B. F., Horn, D. L., Ostrosky-Zeichner, L., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/520980 · Cited by 638
Walsh, T. J., Hiemenz, J. W., Seibel, N. L., Perfect, J. R., Horwith, G., Lee, L., Silber, J. L., DiNubile, M. J., Reboli, A., Bow, E., et al. (1998) · Clinical Infectious Diseases · doi:10.1086/516353 · Cited by 629
Posaconazole Is Effective as Salvage Therapy in Zygomycosis: A Retrospective Summary of 91 Cases
van Burik, J.-A. H., Hare, R. S., Solomon, H. F., Corrado, M. L., & Kontoyiannis, D. P. (2006) · Clinical Infectious Diseases · doi:10.1086/500212 · Cited by 615
Viscoli, C., Girmenia, C., Marinus, A., Collette, L., Martino, P., Vandercam, B., Doyen, C., Lebeau, B., Spence, D., Krcmery, V., et al. (1999) · Clinical Infectious Diseases · doi:10.1086/514731 · Cited by 601 · cited 2×
“glabrata) have been identified in most studies [83, 174, 183].”
BackgroundCombination Antifungal Therapy for Invasive Aspergillosis
Marr, K. A., Boeckh, M., Carter, R. A., Kim, H. W., & Corey, L. (2004) · Clinical Infectious Diseases · doi:10.1086/423380 · Cited by 596
Caillot, D., Couaillier, J.-F., Bernard, A., Casasnovas, O., Denning, D. W., Mannone, L., Lopez, J., Couillault, G., Piard, F., Vagner, O., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.1.253 · Cited by 587
Posaconazole as Salvage Therapy for Zygomycosis
Greenberg, R. N., Mullane, K., van Burik, J.-A. H., Raad, I., Abzug, M. J., Anstead, G., Herbrecht, R., Langston, A., Marr, K. A., Schiller, G., et al. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.1.126-133.2006 · Cited by 555
Intravascular catheter-related infections: advances in diagnosis, prevention, and management
Raad, I., Hanna, H., & Maki, D. (2007) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(07)70235-9 · Cited by 525
Kullberg, B., Sobel, J., Ruhnke, M., Pappas, P., Viscoli, C., Rex, J., Cleary, J., Rubinstein, E., Church, L., Brown, J., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67490-9 · Cited by 521
Self-citationTortorano, A. M., Peman, J., Bernhardt, H., Klingspor, L., Kibbler, C. C., Faure, O., Biraghi, E., Canton, E., Zimmermann, K., Seaton, S., et al. (2004) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-004-1103-y · Cited by 509 · cited 1×
“glabrata) have been identified in most studies [83, 174, 183].”
BackgroundRex, J. H., Pappas, P. G., Karchmer, A. W., Sobel, J., Edwards, J. E., Hadley, S., Brass, C., Vazquez, J. A., Chapman, S. W., Horowitz, H. W., et al. (2003) · Clinical Infectious Diseases · doi:10.1086/374850 · Cited by 495
Combination Polyene‐Caspofungin Treatment of Rhino‐Orbital‐Cerebral Mucormycosis
Reed, C., Bryant, R., Ibrahim, A. S., Edwards, Jr., Filler, S. G., Goldberg, R., & Spellberg, B. (2008) · Clinical Infectious Diseases · doi:10.1086/589857 · Cited by 494
Wingard, J. R., Carter, S. L., Walsh, T. J., Kurtzberg, J., Small, T. N., Baden, L. R., Gersten, I. D., Mendizabal, A. M., Leather, H. L., Confer, D. L., et al. (2010) · Blood · doi:10.1182/blood-2010-02-268151 · Cited by 482
Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial
Brouwer, A. E., Rajanuwong, A., Chierakul, W., Griffin, G. E., Larsen, R. A., White, N. J., & Harrison, T. S. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16301-0 · Cited by 470
Segal, B. H., Herbrecht, R., Stevens, D. A., Ostrosky‐Zeichner, L., Sobel, J., Viscoli, C., Walsh, T. J., Maertens, J., Patterson, T. F., Perfect, J. R., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/590566 · Cited by 468
Pulmonary mucormycosis: Results of medical and surgical therapy
Tedder, M., Spratt, J. A., Anstadt, M. P., Hegde, S. S., Tedder, S. D., & Lowe, J. E. (1994) · The Annals of Thoracic Surgery · doi:10.1016/0003-4975(94)90243-7 · Cited by 452
Mortality and Costs of Acute Renal Failure Associated with Amphotericin B Therapy
Bates, D. W., Su, L., Yu, D. T., Chertow, G. M., Seger, D. L., Gomes, D. R. J., Dasbach, E. J., & Platt, R. (2001) · Clinical Infectious Diseases · doi:10.1086/319211 · Cited by 451
deShazo, R. D., Chapin, K., & Swain, R. E. (1997) · New England Journal of Medicine · doi:10.1056/nejm199707243370407 · Cited by 440
Marty, F. M., Cosimi, L. A., & Baden, L. R. (2004) · New England Journal of Medicine · doi:10.1056/nejm200402263500923 · Cited by 426
Amphotericin B: time for a new “gold standard”
Saravolatz, L. D., Ostrosky-Zeichner, L., Marr, K. A., Rex, J. H., & Cohen, S. H. (2003) · Clinical Infectious Diseases · doi:10.1086/376634 · Cited by 406
Park, W. B., Kim, N.-H., Kim, K.-H., Lee, S. H., Nam, W.-S., Yoon, S. H., Song, K.-H., Choe, P. G., Kim, N. J., Jang, I.-J., et al. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis599 · Cited by 399
Girmenia, C., Pagano, L., Martino, B., D'Antonio, D., Fanci, R., Specchia, G., Melillo, L., Buelli, M., Pizzarelli, G., Venditti, M., et al. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.4.1818-1828.2005 · Cited by 397
Hepatic Candidiasis in Cancer Patients: The Evolving Picture of the Syndrome
THALER, M., PASTAKIA, B., SHAWKER, T. H., O'LEARY, T., & PIZZO, P. A. (1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-1-88 · Cited by 395
Improved outcome in central nervous system aspergillosis, using voriconazole treatment
Schwartz, S. (2005) · Blood · doi:10.1182/blood-2005-02-0733 · Cited by 391
Perruccio, K., Tosti, A., Burchielli, E., Topini, F., Ruggeri, L., Carotti, A., Capanni, M., Urbani, E., Mancusi, A., Aversa, F., et al. (2005) · Blood · doi:10.1182/blood-2005-05-1775 · Cited by 391
Cordonnier, C., Pautas, C., Maury, S., Vekhoff, A., Farhat, H., Suarez, F., Dhédin, N., Isnard, F., Ades, L., Kuhnowski, F., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/597395 · Cited by 389
Groll, A. H., Giri, N., Petraitis, V., Petraitiene, R., Candelario, M., Bacher, J. S., Piscitelli, S. C., & Walsh, T. J. (2000) · The Journal of Infectious Diseases · doi:10.1086/315643 · Cited by 373
Predictors of Pulmonary Zygomycosis versus Invasive Pulmonary Aspergillosis in Patients with Cancer
Chamilos, G., Marom, E. M., Lewis, R. E., Lionakis, M. S., & Kontoyiannis, D. P. (2005) · Clinical Infectious Diseases · doi:10.1086/430710 · Cited by 369
Wingard, J. R., Kubilis, P., Lee, L., Yee, G., White, M., Louise, W., Bowden, R., Anaissie, E., Hiemenz, J., & Lister, J. (1999) · Clinical Infectious Diseases · doi:10.1086/313498 · Cited by 368
Invasive Aspergillosis: Epidemiology, Diagnosis and Management in Immunocompromised Patients
Maschmeyer, G., Haas, A., & Cornely, O. A. (2007) · Drugs · doi:10.2165/00003495-200767110-00004 · Cited by 366
Self-citationNguyen, M. H. (1995) · Archives of Internal Medicine · doi:10.1001/archinte.1995.00430220087009 · Cited by 363
Powderly, W. G., Saag, M. S., Cloud, G. A., Robinson, P., Meyer, R. D., Jacobson, J. M., Graybill, J. R., Sugar, A. M., McAuliffe, V. J., Follansbee, S. E., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199203193261203 · Cited by 353
Candiduria: A Randomized, Double-Blind Study of Treatment with Fluconazole and Placebo
Sobel, J. D., Kauffman, C. A., McKinsey, D., Zervos, M., Vazquez, J. A., Karchmer, A. W., Lee, J., Thomas, C., Panzer, H., Dismukes, W. E., et al. (2000) · Clinical Infectious Diseases · doi:10.1086/313580 · Cited by 343
Factors Associated with Overall and Attributable Mortality in Invasive Aspergillosis
Nivoix, Y., Velten, M., Letscher‐Bru, V., Moghaddam, A., Natarajan‐Amé, S., Fohrer, C., Lioure, B., Bilger, K., Lutun, P., Marcellin, L., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/592255 · Cited by 342
Fusarium Infection in Hematopoietic Stem Cell Transplant Recipients
Nucci, M., Marr, K. A., Queiroz-Telles, F., Martins, C. A., Trabasso, P., Costa, S., Voltarelli, J. C., Colombo, A. L., Imhof, A., Pasquini, R., et al. (2004) · Clinical Infectious Diseases · doi:10.1086/383319 · Cited by 333
Hachem, R., Hanna, H., Kontoyiannis, D., Jiang, Y., & Raad, I. (2008) · Cancer · doi:10.1002/cncr.23466 · Cited by 331
Invasive Aspergillosis in 2002: An Update
Kontoyiannis, D., & Bodey, G. (2002) · European Journal of Clinical Microbiology and Infectious Diseases · doi:10.1007/s10096-002-0699-z · Cited by 326
Leenders, A. C. A. P., Daenen, S., Jansen, R. L. H., Hop, W. C. J., Lowenberg, B., Wijermans, P. W., Cornelissen, J., Herbrecht, R., Lelie, H. V. D., Hoogsteden, H. C., et al. (1998) · British Journal of Haematology · doi:10.1046/j.1365-2141.1998.00944.x · Cited by 319
Invasive aspergillosis in patients with acute myeloid leukemia: a SEIFEM-2008 registry study
Pagano, L., Caira, M., Candoni, A., Offidani, M., Martino, B., Specchia, G., Pastore, D., Stanzani, M., Cattaneo, C., Fanci, R., et al. (2010) · Haematologica · doi:10.3324/haematol.2009.012054 · Cited by 316
Outcome predictors of 84 patients with hematologic malignancies and Fusarium infection
Nucci, M., Anaissie, E. J., Queiroz‐Telles, F., Martins, C. A., Trabasso, P., Solza, C., Mangini, C., Simões, B. P., Colombo, A. L., Vaz, J., et al. (2003) · Cancer · doi:10.1002/cncr.11510 · Cited by 314
Factors associated with mortality in transplant patients with invasive aspergillosis
Baddley, J. W., Andes, D. R., Marr, K. A., Kontoyiannis, D. P., Alexander, B. D., Kauffman, C. A., Oster, R. A., Anaissie, E. J., Walsh, T. J., Schuster, M. G., et al. (2010) · Clinical Infectious Diseases · doi:10.1086/652768 · Cited by 303
Mucormycosis in hematologic patients.
Pagano, L., Offidani, M., Fianchi, L., Nosari, A., Candoni, A., Picardi, M., Corvatta, L., D’Antonio, D., Girmenia, C., Martino, P., et al. (2004) · PubMed · Cited by 302
Raad, I. I., Hachem, R. Y., Herbrecht, R., Graybill, J. R., Hare, R., Corcoran, G., & Kontoyiannis, D. P. (2006) · Clinical Infectious Diseases · doi:10.1086/503425 · Cited by 302
Predictors of Adverse Outcome in Cancer Patients with Candidemia
Anaissie, E. J., Rex, J. H., Uzun, Ö., & Vartivarian, S. (1998) · The American Journal of Medicine · doi:10.1016/s0002-9343(98)00030-8 · Cited by 295
Denning, D. W., Marr, K. A., Lau, W. M., Facklam, D. P., Ratanatharathorn, V., Becker, C., Ullmann, A. J., Seibel, N. L., Flynn, P. M., van Burik, J.-A. H., et al. (2006) · Journal of Infection · doi:10.1016/j.jinf.2006.03.003 · Cited by 294
Self-citationGeorgiadou, S. P., Sipsas, N. V., Marom, E. M., & Kontoyiannis, D. P. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir122 · Cited by 292 · cited 1×
“Such ring-shaped consolidation surrounding a central infiltrate should prompt a diagnostic work-up including bronchoalveolar lavage and biopsy [30, 49, 185].”
BackgroundLeenders, A. C. A. P., Reiss, P., Portegies, P., Clezy, K., Hop, W. C. J., Hoy, J., Borleffs, J. C. C., Allworth, T., Kauffmann, R. H., Jones, P., et al. (1997) · AIDS · doi:10.1097/00002030-199712000-00010 · Cited by 289
Ringden, O., Meunier, F., Tollemar, J., Ricci, P., Tura, S., Kuse, E., Viviani, M. A., Gorin, N. C., Klastersky, J., Fenaux, P., et al. (1991) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/28.suppl_b.73 · Cited by 280
Anaissie, E. J., Darouiche, R. O., Abi-Said, D., Uzun, O., Mera, J., Gentry, L. O., Williams, T., Kontoyiannis, D. P., Karl, C. L., & Bodey, G. P. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/23.5.964 · Cited by 278
Guide to Development of Practice Guidelines
Kish, M. A. (2001) · Clinical Infectious Diseases · doi:10.1086/319366 · Cited by 276
Ullmann, A. J., Cornely, O. A., Burchardt, A., Hachem, R., Kontoyiannis, D. P., Töpelt, K., Courtney, R., Wexler, D., Krishna, G., Martinho, M., et al. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.2.658-666.2006 · Cited by 273
Self-citationEpidemiology and outcome of Scedosporium prolificans infection, a review of 162 cases
Rodriguez-Tudela, J. L., Rodriguez-Tudela, J. L., Berenguer, J., Guarro, J., Kantarcioglu, A. S., Horre, R., Sybren De Hoog, G., & Cuenca-Estrella, M. (2009) · Medical Mycology · doi:10.1080/13693780802524506 · Cited by 269
Epidemiology and outcome of infections due to Aspergillus terreus : 10‐year single centre experience
Lass‐Flörl, C., Griff, K., Mayr, A., Petzer, A., Gastl, G., Bonatti, H., Freund, M., Kropshofer, G., Dierich, M. P., & Nachbaur, D. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05763.x · Cited by 266
Denning, D. W., Marinus, A., Cohen, J., Spence, D., Herbrecht, R., Pagano, L., Kibbler, C., Kermery, V., Offner, F., Cordonnier, C., et al. (1998) · Journal of Infection · doi:10.1016/s0163-4453(98)80173-4 · Cited by 256
Current Treatment Strategies for Disseminated Candidiasis
Spellberg, B. J., Filler, S. G., & Edwards, J. E. (2006) · Clinical Infectious Diseases · doi:10.1086/499057 · Cited by 256
Intravascular Catheter Exchange and Duration of Candidemia
Rex, J. H., Bennett, J. E., Sugar, A. M., Pappas, P. G., Serody, J., Edwards, J. E., Washburn, R. G., NIAID Mycoses Study Group, & Candidemia Study Group (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/21.4.994 · Cited by 252
Activity of posaconazole in the treatment of central nervous system fungal infections
Pitisuttithum, P., Negroni, R., Graybill, J. R., Bustamante, B., Pappas, P., Chapman, S., Hare, R. S., & Hardalo, C. J. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki288 · Cited by 251
Ellis, M., Spence, D., de Pauw, B., Meunier, F., Marinus, A., Collette, L., Sylvester, R., Meis, J., Boogaerts, M., Selleslag, D., et al. (1998) · Clinical Infectious Diseases · doi:10.1086/515033 · Cited by 251
Invasive zygomycosis in India: experience in a tertiary care hospital
Chakrabarti, A., Chatterjee, S. S., Das, A., Panda, N., Shivaprakash, M. R., Kaur, A., Varma, S. C., Singhi, S., Bhansali, A., & Sakhuja, V (2009) · Postgraduate Medical Journal · doi:10.1136/pgmj.2008.076463 · Cited by 244
Marks, D. I., Pagliuca, A., Kibbler, C. C., Glasmacher, A., Heussel, C., Kantecki, M., Miller, P. J. S., Ribaud, P., Schlamm, H. T., Solano, C., et al. (2011) · British Journal of Haematology · doi:10.1111/j.1365-2141.2011.08838.x · Cited by 243
Interaction of Common Azole Antifungals with P Glycoprotein
Wang, E.-J., Lew, K., Casciano, C. N., Clement, R. P., & Johnson, W. W. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.1.160-165.2002 · Cited by 233
Francis, P., & Walsh, T. J. (1992) · Clinical Infectious Diseases · doi:10.1093/clind/15.6.1003 · Cited by 232
Bicanic, T., Wood, R., Meintjes, G., Rebe, K., Brouwer, A., Loyse, A., Bekker, L., Jaffar, S., & Harrison, T. (2008) · Clinical Infectious Diseases · doi:10.1086/588792 · Cited by 232
Phillips, P., Shafran, S., Garber, G., Rotstein, C., Smaill, F., Fong, I., Salit, I., Miller, M., Williams, K., Conly, J. M., et al. (1997) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf01726360 · Cited by 221
Anaissie, E., Bodey, G. P., Kantarjian, H., David, C., Barnett, K., Bow, E., Defelice, R., Downs, N., File, T., Karam, G., et al. (1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90006-j · Cited by 220
Troke, P. F., Hockey, H. P., & Hope, W. W. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01083-10 · Cited by 218
Safety of Long-Term Oral Posaconazole Use in the Treatment of Refractory Invasive Fungal Infections
Raad, I. I., Graybill, J. R., Bustamante, A. B., Cornely, O. A., Gaona-Flores, V., Afif, C., Graham, D. R., Greenberg, R. N., Hadley, S., Langston, A., et al. (2006) · Clinical Infectious Diseases · doi:10.1086/504328 · Cited by 217
Self-citationBetts, R. F., Nucci, M., Talwar, D., Gareca, M., Queiroz‐Telles, F., Bedimo, R. J., Herbrecht, R., Ruiz‐Palacios, G., Young, J. H., Baddley, J. W., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/598933 · Cited by 214
Reversed Halo Sign in Invasive Pulmonary Fungal Infections
Wahba, H., Truong, M. T., Lei, X., Kontoyiannis, D. P., & Marom, E. M. (2008) · Clinical Infectious Diseases · doi:10.1086/587991 · Cited by 214
Maertens, J., Glasmacher, A., Herbrecht, R., Thiebaut, A., Cordonnier, C., Segal, B. H., Killar, J., Taylor, A., Kartsonis, N., Patterson, T. F., et al. (2006) · Cancer · doi:10.1002/cncr.22348 · Cited by 212
Epidemiology of Candida albicans Infections and Role of Non-Candidaalbicans Yeasts
Ruhnke, M. (2006) · Current Drug Targets · doi:10.2174/138945006776359421 · Cited by 210
Self-citationPascual, A., Csajka, C., Buclin, T., Bolay, S., Bille, J., Calandra, T., & Marchetti, O. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis437 · Cited by 207
Recombinant Interferon‐γ1b as Adjunctive Therapy for AIDS‐Related Acute Cryptococcal Meningitis
Pappas, P. G., Bustamante, B., Ticona, E., Hamill, R. J., Johnson, P. C., Reboli, A., Aberg, J., Hasbun, R., & Hsu, H. H. (2004) · The Journal of Infectious Diseases · doi:10.1086/420829 · Cited by 202
Forty-one recent cases of invasive zygomycosis from a global clinical registry
Ruping, M. J. G. T., Heinz, W. J., Kindo, A. J., Rickerts, V., Lass-Florl, C., Beisel, C., Herbrecht, R., Roth, Y., Silling, G., Ullmann, A. J., et al. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp430 · Cited by 201
Self-citationTrifilio, S., Pennick, G., Pi, J., Zook, J., Golf, M., Kaniecki, K., Singhal, S., Williams, S., Winter, J., Tallman, M., et al. (2007) · Cancer · doi:10.1002/cncr.22568 · Cited by 199
Howden, B. P., Slavin, M. A., Schwarer, A. P., & Mijch, A. M. (2003) · European Journal of Clinical Microbiology and Infectious Diseases · doi:10.1007/s10096-002-0877-z · Cited by 198
Sharkey, P. K., Graybill, J. R., Johnson, E. S., Hausrath, S. G., Pollard, R. B., Kolokathis, A., Mildvan, D., Fan-Havard, P., Eng, R. H. K., Patterson, T. F., et al. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/22.2.315 · Cited by 197
Hepatosplenic candidiasis: Successful treatment with fluconazole
Kauffman, C. A., Bradley, S. F., Ross, S. C., & Weber, D. R. (1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90005-i · Cited by 195
Nussbaum, J. C., Jackson, A., Namarika, D., Phulusa, J., Kenala, J., Kanyemba, C., Jarvis, J. N., Jaffar, S., Hosseinipour, M. C., Kamwendo, D., et al. (2010) · Clinical Infectious Diseases · doi:10.1086/649861 · Cited by 194
Caillot, D., Thiébaut, A., Herbrecht, R., de Botton, S., Pigneux, A., Bernard, F., Larché, J., Monchecourt, F., Alfandari, S., & Mahi, L. (2007) · Cancer · doi:10.1002/cncr.23109 · Cited by 190 · cited 1×
“A randomized pilot study comparing the combination of L-AmB plus caspofungin (standard dosages) to high-dose L-AmB in patients with hematological malignancies resulted in a better response with the combination at the end of treatment, but similar overall survival after 12 weeks and the number of patients included (n =…”
BackgroundOstrosky-Zeichner, L., Kontoyiannis, D., Raffalli, J., Mullane, K. M., Vazquez, J., Anaissie, E. J., Lipton, J., Jacobs, P., Rensburg, J. H. J., Rex, J. H., et al. (2005) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-005-0024-8 · Cited by 189
Anaissie, E. J., Vartivarian, S. E., Abi-Said, D., Uzun, O., Pinczowski, H., Kontoyiannis, D. P., Khoury, P., Papadakis, K., Gardner, A., Raad, I. I., et al. (1996) · The American Journal of Medicine · doi:10.1016/s0002-9343(96)80072-6 · Cited by 188
International Retrospective Analysis of 73 Cases of Invasive Fusariosis Treated with Voriconazole
Lortholary, O., Obenga, G., Biswas, P., Caillot, D., Chachaty, E., Bienvenu, A.-L., Cornet, M., Greene, J., Herbrecht, R., Lacroix, C., et al. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00286-10 · Cited by 184
Treatment-related risk factors for hospital mortality in Candida bloodstream infections
Labelle, A. J., Micek, S. T., Roubinian, N., & Kollef, M. H. (2008) · Critical Care Medicine · doi:10.1097/ccm.0b013e31818b3477 · Cited by 181 · cited 1×
“If the central venous lines are retained, the duration of candidemia increases (from 3 to 6 days) as does the mortality of patients [22, 87, 145, 193].”
BackgroundBow, E. J., Loewen, R., Cheang, M. S., & Schacter, B. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/21.2.361 · Cited by 181
The epidemiology of nephrotoxicity associated with conventional amphotericin B therapy
Harbarth, S., Pestotnik, S. L., Lloyd, J. F., Burke, J. P., & Samore, M. H. (2001) · The American Journal of Medicine · doi:10.1016/s0002-9343(01)00928-7 · Cited by 176
Hamill, R. J., Sobel, J. D., El‐Sadr, W., Johnson, P. C., Graybill, J. R., Javaly, K., & Barker, D. E. (2010) · Clinical Infectious Diseases · doi:10.1086/653606 · Cited by 175
Mills, W., Chopra, R., Linch, D. C., & Goldstone, A. H. (1994) · British Journal of Haematology · doi:10.1111/j.1365-2141.1994.tb04825.x · Cited by 171
Invasive fusariosis in patients with hematologic malignancies at a cancer center: 1998–2009
Campo, M., Lewis, R. E., & Kontoyiannis, D. P. (2010) · Journal of Infection · doi:10.1016/j.jinf.2010.01.010 · Cited by 171
Treatment of Non-Aspergillus Moulds in Immunocompromised Patients, with Amphotericin B Lipid Complex
Perfect, J. R. (2005) · Clinical Infectious Diseases · doi:10.1086/429331 · Cited by 167
Ruan, S., Chien, J., & Hsueh, P. (2009) · Clinical Infectious Diseases · doi:10.1086/599614 · Cited by 166
Clinical pharmacology of antifungal compounds
Groll, A. H., Gea‐Banacloche, J., Glasmacher, A., Just‐Nübling, G., Maschmeyer, G., & Walsh, T. J. (2003) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(02)00068-5 · Cited by 165
Self-citationScedosporium Infection in a Tertiary Care Cancer Center: A Review of 25 Cases from 1989-2006
Lamaris, G. A., Chamilos, G., Lewis, R. E., Safdar, A., Raad, I. I., & Kontoyiannis, D. P. (2006) · Clinical Infectious Diseases · doi:10.1086/509579 · Cited by 163
Wenzel, R. P., & Gennings, C. (2005) · Clinical Infectious Diseases · doi:10.1086/430923 · Cited by 159
Management of central venous catheters in patients with cancer and candidemia
Raad, I., Hanna, H., Boktour, M., Girgawy, E., Danawi, H., Mardani, M., Kontoyiannis, D., Darouiche, R., Hachem, R., & Bodey, G. P. (2004) · Clinical Infectious Diseases · doi:10.1086/382874 · Cited by 159
Caillot, D., Bassaris, H., McGeer, A., Arthur, C., Prentice, H. G., Seifert, W., & De Beule, K. (2001) · Clinical Infectious Diseases · doi:10.1086/323020 · Cited by 159
Infective endocarditis in intravenous drug abusers and HIV-1 infected patients
Miró, J. M., del Rı́o, A., & Mestres, C. A. (2002) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(01)00008-3 · Cited by 158
Adjuvant Corticosteroid Therapy for Chronic Disseminated Candidiasis
Legrand, F., Lecuit, M., Dupont, B., Bellaton, E., Huerre, M., Rohrlich, P.-S., & Lortholary, O. (2008) · Clinical Infectious Diseases · doi:10.1086/527390 · Cited by 157 · cited 1×
“In contrast, newer data suggest that hepatosplenic candidosis may represent an immune reconstitution syndrome as steroids (in addition to antifungal treatment) can lead to a rapid resolution of clinical signs [93] (CIII).”
ResultTherapeutic Drug Monitoring of Antifungals: Pharmacokinetic and Pharmacodynamic Considerations
Smith, J., & Andes, D. (2008) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0b013e318167d0e0 · Cited by 156
Randomized phase III study of granulocyte transfusions in neutropenic patients
Seidel, M. G., Peters, C., Wacker, A., Northoff, H., Moog, R., Boehme, A., Silling, G., Grimminger, W., & Einsele, H. (2008) · Bone Marrow Transplantation · doi:10.1038/bmt.2008.237 · Cited by 156
Self-citationBreakthrough Trichosporonosis in Patients with Hematologic Malignancies Receiving Micafungin
Matsue, K., Uryu, H., Koseki, M., Asada, N., & Takeuchi, M. (2006) · Clinical Infectious Diseases · doi:10.1086/500323 · Cited by 156
Viscoli, C., Herbrecht, R., Akan, H., Baila, L., Sonet, A., Gallamini, A., Giagounidis, A., Marchetti, O., Martino, R., Meert, L., et al. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp355 · Cited by 154
Self-citationHerbrecht, R., Maertens, J., Baila, L., Aoun, M., Heinz, W., Martino, R., Schwartz, S., Ullmann, A. J., Meert, L., Paesmans, M., et al. (2010) · Bone Marrow Transplantation · doi:10.1038/bmt.2009.334 · Cited by 149 · cited 1×
“At week 6 and week 12, the survival rate was 79 and 50 %, respectively [68].”
BackgroundSelf-citationRuhnke, M., Rickerts, V., Cornely, O. A., Buchheidt, D., Glöckner, A., Heinz, W., Höhl, R., Horré, R., Karthaus, M., Kujath, P., et al. (2011) · Mycoses · doi:10.1111/j.1439-0507.2011.02040.x · Cited by 148
Self-citationTreatment of 21 Cases of Invasive Mucormycosis with Amphotericin B Colloidal Dispersion
Herbrecht, R., Letscher‐Bru, V., Bowden, R. A., Kusne, S., Anaissie, E. J., Graybill, J. R., Noskin, G. A., Oppenheim, B. A., Andrès, E., & Pietrelli, L. A. (2001) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s100960100528 · Cited by 142
Loyse, A., Wilson, D., Meintjes, G., Jarvis, J. N., Bicanic, T. A., Bishop, L., Rebe, K. B., Williams, A., Jaffar, S. S., Bekker, L., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir745 · Cited by 141
Hachem, R. Y., Kontoyiannis, D. P., Boktour, M. R., Afif, C., Cooksley, C. D., Bodey, G. P., Chatzinikolaou, I., Perego, C., Kantarjian, H. M., & RAAD, I. I. (2004) · Cancer · doi:10.1002/cncr.20554 · Cited by 140
van Burik, J. H., Hare, R. S., Solomon, H. F., Corrado, M. L., & Kontoyiannis, D. P. (2006) · Clinical Infectious Diseases · Cited by 140
Caspofungin for the treatment of less common forms of invasive candidiasis
Cornely, O. A., Lasso, M., Betts, R. F., Климко, Н. Н., Vázquez, J. A., Dobb, G. J., Vélez, J. D., Williams‐Diaz, A., Lipka, J., Taylor, A., et al. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm169 · Cited by 137
Self-citationLiposomal amphotericin B treatment for neonatal fungal infections
SCARCELLA, A., PASQUARIELLO, M. B., GIUGLIANO, B., VENDEMMIA, M., & DE LUCIA, A. (1998) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199802000-00013 · Cited by 135
Voriconazole Salvage Treatment of Invasive Candidiasis
Ostrosky-Zeichner, L. L., Lashof, A. M. L. O., Kullberg, B. J., & Rex, J. H. (2003) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-003-1014-3 · Cited by 134
Ueda, K., Nannya, Y., Kumano, K., Hangaishi, A., Takahashi, T., Imai, Y., & Kurokawa, M. (2009) · International Journal of Hematology · doi:10.1007/s12185-009-0296-3 · Cited by 131
Pappas, P. G., Rotstein, C. M. F., Rf, B., Nucci, M., Talwar, D., Waele, J. J. D., Jm, D. L. V. V., Dupont, B., Horn, D., Ostrosky‐Zeichner, L., et al. (2008) · Ghent University Academic Bibliography (Ghent University) · Cited by 130
Hübel, K., Carter, R. A., Liles, W. C., Dale, D. C., Price, T. H., Bowden, R. A., Rowley, S. D., Chauncey, T. R., Bensinger, W., & Boeckh, M. (2002) · Transfusion · doi:10.1046/j.1537-2995.2002.00249.x · Cited by 128
Immunotherapy for Fungal Infections
Segal, B. H., Kwon‐Chung, J., Walsh, T. J., Klein, B. S., Battiwalla, M., Almyroudis, N. G., Holland, S. M., & Romani, L. R. (2006) · Clinical Infectious Diseases · doi:10.1086/499811 · Cited by 125
Anaissie, E. J., Gokaslan, A., Hachem, R. Y., Rubin, R., Griffin, G., Robinson, R. R., Sobel, J. D., & Bodey, G. P. (1992) · Clinical Infectious Diseases · doi:10.1093/clind/15.5.781 · Cited by 124
Hebart, H. F., Klingspor, L., Klingebiel, T. E., Loeffler, J., Tollemar, J. G., Ljungman, P. T., Wandt, H., Schaefer‐Eckart, K., Dornbusch, H. J., Meisner, C., et al. (2008) · Bone Marrow Transplantation · doi:10.1038/bmt.2008.355 · Cited by 119
Fatal Trichosporon fungemia in patients with hematologic malignancies
Suzuki, K., Nakase, K., Kyo, T., Kohara, T., Sugawara, Y., Shibazaki, T., Oka, K., Tsukada, T., & Katayama, N. (2010) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2010.01410.x · Cited by 118
Cryptococcosis in Patients with Cancer
Kontoyiannis, D. P., Ludwig‐Peitsch, W., Reddy, B. T., Whimbey, E. E., Han, X.-Y., Bodey, G. P., & Rolston, K. V. (2001) · Clinical Infectious Diseases · doi:10.1086/320524 · Cited by 117
Ullmann, A. J., Sanz, M. Á., Tramarin, A., Barnes, R. A., Wu, W., Gerlach, B., Krobot, K. J., Gerth, W. C., & on behalf of the Longitudinal Evaluation of Antifungal Drugs (LEAD I) Investigators (2006) · Clinical Infectious Diseases · doi:10.1086/505969 · Cited by 117
Self-citationKontoyiannis, D. P., Ratanatharathorn, V., Young, J. H., Raymond, J. M., Laverdière, M., Denning, D. W., Patterson, T. F., Facklam, D., Kovanda, L. L., Arnold, L., et al. (2008) · Transplant Infectious Disease · doi:10.1111/j.1399-3062.2008.00349.x · Cited by 110
Walsh, T. J., Whitcomb, P., Piscitelli, S., Figg, W. D., Hill, S., Chanock, S. J., Jarosinski, P., Gupta, R., & Pizzo, P. A. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.9.1944 · Cited by 109
Pascual, A., Nieth, V., Calandra, T., Billé, J., Bolay, S., Decosterd, L. A., Buclin, T., Majcherczyk, P. A., Sanglard, D., & Marchetti, O. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00957-06 · Cited by 106
Einsele, H., Bertz, H., Beyer, J., Kiehl, M. G., Runde, V., Kölb, H.-J., Holler, E., Beck, R., Schwerdfeger, R., Schumacher, U., et al. (2003) · Annals of Hematology · doi:10.1007/s00277-003-0772-4 · Cited by 105
Self-citationSansone‐Parsons, A., Krishna, G., Calzetta, A., Wexler, D. B., Kantesaria, B. S., Rosenberg, M. A., & Saltzman, M. A. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.5.1881-1883.2006 · Cited by 104
Impact of high‐dose granulocyte transfusions in patients with cancer with candidemia
Safdar, A., Hanna, H. A., Boktour, M. R., Kontoyiannis, D. P., Hachem, R. Y., Lichtiger, B., Freireich, E. J., & RAAD, I. I. (2004) · Cancer · doi:10.1002/cncr.20710 · Cited by 103
Schwartz, S., Reisman, A. L., & Troke, P. F. (2011) · Infection · doi:10.1007/s15010-011-0108-6 · Cited by 101
Pagano, L., Mele, L., Fianchi, L., Melillo, L. M. A., Martino, B., D’Antonio, D., Tosti, M. E., Posteraro, B., Sanguinetti, M., Trapè, G., et al. (2002) · PubMed · Cited by 101
Bhat, S. V., Paterson, D. L., Rinaldi, M. G., & Veldkamp, P. J. (2006) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540600786564 · Cited by 100
Treatment of Candida albicans fungaemia with fluconazole
Graninger, W., Presteril, E., Schneeweiß, B., Teleky, B. K., & Georgopoulos, A. P. (1993) · Journal of Infection · doi:10.1016/0163-4453(93)92761-k · Cited by 99
Böhme, A., Ruhnke, M., Buchheidt, D., Karthaus, M., Einsele, H., Guth, S., Heussel, G., Heußel, C. P., Junghanß, C., Kern, W. V., et al. (2003) · Annals of Hematology · doi:10.1007/s00277-003-0767-1 · Cited by 95
Self-citationPenack, O., Beinert, T., Buchheidt, D., Einsele, H., Hebart, H. F., Kiehl, M. G., Massenkeil, G., Schiel, X., Schleicher, J., Staber, P. B., et al. (2006) · Annals of Hematology · doi:10.1007/s00277-006-0096-2 · Cited by 95
Self-citationCNS Aspergillosis: Recognition, Diagnosis and Management
Ruhnke, M., Kofla, G., Otto, K., & Schwartz, S. (2007) · CNS Drugs · doi:10.2165/00023210-200721080-00004 · Cited by 95
Self-citationMousset, S., Hermann, S., Klein, S., Bialleck, H., Duchscherer, M., Bomke, B., Waßmann, B., Böhme, A., Hoelzer, D. F., & Martin, H. (2005) · Annals of Hematology · doi:10.1007/s00277-005-1055-z · Cited by 94
Self-citationSurgical Management of Invasive Pulmonary Aspergillosis in Neutropenic Patients
Bernard, A., Caillot, D., Couaillier, J. F., Casasnovas, O., Guy, H., & Favre, J. P. (1997) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(97)00858-8 · Cited by 94
Phase II Dose Escalation Study of Caspofungin for Invasive Aspergillosis
Cornely, O. A., Vehreschild, J. J., Vehreschild, M. J. G. T., Würthwein, G., Arenz, D., Schwartz, S., Heussel, C. P., Silling, G., Mahne, M., Franklin, J., et al. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05134-11 · Cited by 93 · cited 1×
“100 mg/day) showed a trend towards improved efficacy in subgroups of patients (APACHE II score >20, neutropenia) andmight be used in selected patients [19, 36, 128].”
MethodSelf-citationLeu, H.-S., & Huang, C.-T. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/20.5.1152 · Cited by 93
Breakthrough Trichosporonosis in a Bone Marrow Transplant Recipient Receiving Caspofungin Acetate
Goodman, D., Pamer, E. G., Jakubowski, A. A., Morris, C. D., & Sepkowitz, K. A. (2002) · Clinical Infectious Diseases · doi:10.1086/341305 · Cited by 92
Hepatosplenic Candidiasis in Patients with Acute Leukemia: Incidence and Prognostic Implications
Anttila, V., Elonen, E., Nordling, S., Sivonen, K., Ruutu, T., & Ruutu, P. (1997) · Clinical Infectious Diseases · doi:10.1093/clinids/24.3.375 · Cited by 90
Fournier, S., Pavageau, W., Feuillhade, M., Deplus, S., Zagdanski, A., VEROLA, O., Dombret, H., & Molina, J. (2002) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-002-0841-y · Cited by 89
Wolf, H., Leithäuser, M., Maschmeyer, G., Salwender, H. J., Klein, U., Chaberny, I. F., Weißinger, F., Buchheidt, D., Ruhnke, M., Egerer, G., et al. (2008) · Annals of Hematology · doi:10.1007/s00277-008-0509-5 · Cited by 88
Self-citationSafdar, A., Rodriguez, G. H., Ohmagari, N., Kontoyiannis, D. P., Rolston, K. V. I., RAAD, I. I., & Champlin, R. E. (2005) · Cancer · doi:10.1002/cncr.20883 · Cited by 87
Aspergillus sinusitis in cancer patients
Viollier, A.-F., Peterson, D. E., Jongh, C. A. D., Newman, K. A., Gray, W. C., Sutherland, J. C., Moody, M. A., & Schimpff, S. C. (1986) · Cancer · doi:10.1002/1097-0142(19860715)58:2<366::aid-cncr2820580228>3.0.co;2-v · Cited by 87
Clinical and Economic Outcomes of Conventional Amphotericin B–Associated Nephrotoxicity
Harbarth, S., Burke, J. P., Lloyd, J. F., Evans, R. S., Pestotnik, S. L., & Samore, M. H. (2002) · Clinical Infectious Diseases · doi:10.1086/344468 · Cited by 86
Walsh, T. J. (1998) · Clinical Infectious Diseases · doi:10.1086/514718 · Cited by 83
Primary treatment of zygomycosis with liposomal amphotericin B: analysis of 28 cases
Shoham, S., Magill, S. S., Merz, W. G., Gonzalez, C. E., Seibel, N. L., Buchanan, W. L., Knudsen, T. A., Sarkisova, T. A., & Walsh, T. J. (2010) · Medical Mycology · doi:10.3109/13693780903311944 · Cited by 83
Hepatosplenic candidiasis in patients with acute leukaemia
Sallah, S., Semelka, R. C., Wehbie, R. S., Sallah, W., Nguyen, N. P., & Vos, P. W. (1999) · British Journal of Haematology · doi:10.1046/j.1365-2141.1999.01592.x · Cited by 82
RAAD, I. I., Hanna, H. A., Boktour, M. R., Jiang, Y., Torres, H. A., Afif, C., Kontoyiannis, D. P., & Hachem, R. Y. (2007) · Leukemia · doi:10.1038/sj.leu.2405065 · Cited by 76
Treatment of invasive Candida and invasive Aspergillus infections in adult haematological patients
Herbrecht, R., Flückiger, U. M., Gachot, B., Ribaud, P., Thiébaut, A., & Cordonnier, C. (2007) · European Journal of Cancer Supplements · doi:10.1016/j.ejcsup.2007.06.007 · Cited by 73
Bayramoğlu, G., Sönmez, M., Tosun, İ., Aydın, K., & Aydın, F. (2007) · Infection · doi:10.1007/s15010-007-6278-6 · Cited by 72
Chandrasekar, P. H., & Ito, J. I. (2005) · Clinical Infectious Diseases · doi:10.1086/429333 · Cited by 71
Fungal Biofilms and Antimycotics
Chandra, J., Zhou, G., & Ghannoum, M. A. (2005) · Current Drug Targets · doi:10.2174/138945005774912762 · Cited by 70
Matt, P., Bernet, F. H., Habicht, J. M., Gambazzi, F., Gratwohl, A. A., Zerkowski, H., & Tamm, M. (2004) · CHEST Journal · doi:10.1378/chest.126.6.1783 · Cited by 68
Muñóz, P., Singh, N., & Bouza, E. (2006) · Current Opinion in Infectious Diseases · doi:10.1097/01.qco.0000235164.70678.97 · Cited by 67
Kontoyiannis, D. P., & Lewis, R. E. (2003) · Drug Resistance Updates · doi:10.1016/j.drup.2003.08.003 · Cited by 67
A review of GermanScedosporium prolificanscases from 1993 to 2007
Tintelnot, K., Just‐Nübling, G., Horré, R., Graf, B., Sobottka, I., Seibold, M., Haas, A. V., Kaben, U., & de Hoog, S. (2009) · Medical Mycology · doi:10.1080/13693780802627440 · Cited by 67
Asada, N., Uryu, H., Koseki, M., Takeuchi, M., Komatsu, M., & Matsue, K. (2006) · Clinical Infectious Diseases · doi:10.1086/505970 · Cited by 65
von Eiff, M., Essink, M., Roos, N., Hiddemann, W., Büchner, T., & van de Loo, J. (1990) · Annals of Hematology · doi:10.1007/bf01728792 · Cited by 62
Kontoyiannis, D. P., Reddy, B. T., Hanna, H. A., Bodey, G. P., Tarrand, J. T., & RAAD, I. I. (2002) · Infection Control and Hospital Epidemiology · doi:10.1086/502104 · Cited by 61
Granulocyte Transfusion: Current Status
Price, T. H. (2006) · Seminars in Hematology · doi:10.1053/j.seminhematol.2006.09.015 · Cited by 60
Hachem, R. Y., Boktour, M. R., Hanna, H. A., Husni, R., Torres, H. A., Afif, C., Kontoyiannis, D. P., & RAAD, I. I. (2008) · Cancer · doi:10.1002/cncr.23311 · Cited by 60
Treatment of Candida Infections with Amphotericin B Lipid Complex
Ito, J. I., & Hooshmand-Rad, R. (2005) · Clinical Infectious Diseases · doi:10.1086/429330 · Cited by 60
Cited by
The clinical spectrum of pulmonary aspergillosis
Kosmidis, C., & Denning, D. W. (2015) · Thorax · doi:10.1136/thoraxjnl-2014-206291 · Cited by 850
Gould, F. K., Denning, D. W., Elliott, T. S. J., Foweraker, J., Perry, J. D., Prendergast, B. D., Sandoe, J. A. T., Spry, M. J., & Watkin, R. W. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr450 · Cited by 593
Ullmann, A. J., Akova, M., Herbrecht, R., Viscoli, C., Arendrup, M. C., Arikan-Akdagli, S., Bassetti, M., Bille, J., Calandra, T., Castagnola, E., et al. (2012) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12041 · Cited by 334
Self-citationCordonnier, C., Rovira, M., Maertens, J., Olavarria, E., Faucher, C., Bilger, K., Pigneux, A., Cornely, O. A., Ullmann, A. J., Bofarull, R. M., et al. (2010) · Haematologica · doi:10.3324/haematol.2009.020073 · Cited by 137
Self-citationKontoyiannis, D. P., Yang, H., Song, J., Kelkar, S. S., Yang, X., Azie, N., Harrington, R., Fan, A., Lee, E., & Spalding, J. R. (2016) · BMC Infectious Diseases · doi:10.1186/s12879-016-2023-z · Cited by 132
Metadata
- Authors
- Mousset, S., Buchheidt, D., Heinz, W., Ruhnke, M., Cornely, O. A., Egerer, G., Krüger, W., Link, H., Neumann, S., Ostermann, H., Panse, J., Penack, O., Rieger, C., Schmidt-Hieber, M., Silling, G., Südhoff, T., Ullmann, A. J., Wolf, H.-H., Maschmeyer, G., & Böhme, A.
- Venue
- Annals of Hematology
- Published
- 2013-09-12
- Volume
- 93
- Issue
- 1
- Pages
- 13-32
- ISSN
- 0939-5555 (ISSN-L)
- 1432-0584
- OpenAlex
- W2158382206
- Cited by
- 255
- References
- 232
- FWCI
- 16.38
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.